শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

ইঙ্গিত

Omeprol is used to treat gastric and duodenal ulcers, including those associated with NSAID use, and as prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer. It is also indicated for gastro-esophageal reflux disease and its long-term management, acid-related dyspepsia, and severe ulcerating reflux esophagitis. Other uses include prophylaxis of acid aspiration during general anesthesia, Zollinger-Ellison syndrome, and Helicobacter pylori-induced peptic ulcer.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Omeprazole is a substituted benzimidazole that reduces gastric acid secretion. It works by blocking the hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell. After it is taken by mouth, the antisecretory effect begins within one hour, reaches its maximum within two hours, and suppresses acid secretion for up to 72 hours. Once the drug is stopped, secretory activity returns gradually over 3 to 5 days.

Pregnancy & Breastfeeding

Results from three prospective epidemiological studies show no adverse effects of Omeprazole on pregnancy or on the health of the fetus or newborn, so it can be used during pregnancy. There is no information on whether Omeprazole passes into breast milk or what effect it may have on a nursing infant. For this reason, breast-feeding should be discontinued if the use of Omeprazole is considered essential.

Use in Children & Adolescents: The safety and effectiveness of Omeprazole have not been established in pediatric patients under 18 years of age.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: Dosage Oral use. For benign gastric and duodenal ulcer, the usual dose is 20 mg once daily, given for 4 weeks in duodenal ulceration and for 8 weeks in gastric ulceration; in severe or recurrent cases the dose may be increased to 40 mg daily. The maintenance dose for recurrent duodenal ulcer is 20 mg once daily, and for prevention of relapse in duodenal ulcer the dose is 10 to 20 mg daily. For NSAID associated duodenal or gastric ulcer, the dose is 20 mg once daily for 4 weeks, continued for a further 4 weeks if not fully healed; 20 mg once daily is also used as prophylaxis in patients with a history of NSAID associated duodenal or gastric ulcers. For gastro esophageal reflux disease, the dose is 20 mg once daily for 4 weeks, continued for a further 4 to 8 weeks if not fully healed; 40 mg once daily has been given for 8 weeks in gastro esophageal reflux disease that is refractory to other treatment, and the maintenance dose is 20 mg once daily. For long term management of acid reflux disease, the dose is 10 to 20 mg daily. For acid related dyspepsia, the dose is 10 to 20 mg once daily for 2 to 4 weeks. For prophylaxis of acid aspiration, 40 mg is given on the preceding evening, then a further 40 mg 2 to 6 hours before surgery. For Zollinger Ellison syndrome (ZES), the initial dose is 60 mg once daily, with a usual range of 20 to 120 mg daily; if the daily dose exceeds 80 mg, it should be given in two divided doses. For Helicobacter pylori eradication in peptic ulcer disease, omeprazole is recommended at a dose of 20 mg twice daily together with antimicrobial agents, using one of the following combinations: amoxicillin 500 mg with metronidazole 400 mg, both three times a day for one week; or clarithromycin 250 mg with metronidazole 400 mg, both twice a day for one week; or amoxicillin 1 g with clarithromycin 500 mg, both twice a day for one week. For paediatric use in severe ulcerating reflux esophagitis in children over 1 year, if body weight is 10 to 20 kg the dose is 10 to 20 mg once daily for 4 to 12 weeks, and if body weight is over 20 kg the dose is 20 to 40 mg once daily for 4 to 12 weeks. Intravenous injection. For prophylaxis of acid aspiration, omeprazole 40 mg is given slowly as an intravenous injection over about 5 minutes, one hour before surgery. For duodenal ulcer, gastric ulcer or reflux oesophagitis in patients for whom oral medication is not suitable, omeprazole 40 mg once daily by IV injection is recommended. For Zollinger Ellison syndrome (ZES), the recommended initial intravenous dose is 60 mg daily; higher daily doses may be needed and should be adjusted individually, and when the daily dose exceeds 60 mg it should be divided and given twice daily.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.